DEXA scan Introduction (What it is)
A DEXA scan is a medical imaging test that measures bone density.
It uses two low-dose X-ray energy levels to estimate how much mineral is in bone.
It is commonly used to assess osteoporosis risk and monitor bone health over time.
In cancer care, it is often used to evaluate treatment-related bone loss and fracture risk.
Why DEXA scan used (Purpose / benefits)
The main purpose of a DEXA scan is to quantify bone mineral density (BMD) in a standardized way. Bone health matters in oncology because many cancers and cancer treatments can affect the skeleton directly or indirectly. Some patients lose bone density due to treatment-induced changes in hormones, reduced mobility, nutritional challenges, inflammation, or medications that impact bone remodeling.
In general clinical practice, DEXA scan helps clinicians:
- Detect low bone density early (before a fracture occurs), supporting prevention-focused care.
- Estimate fracture risk as part of a broader clinical picture (age, prior fractures, family history, medications, and other risk factors may be considered alongside DEXA results).
- Establish a baseline before starting therapies known to affect bone (for example, hormone therapies used in breast or prostate cancer).
- Monitor changes over time, such as response to bone-strengthening strategies or ongoing bone loss during cancer treatment or survivorship.
- Support survivorship care planning, where long-term side effects (late effects) and quality of life become a major focus.
DEXA scan is not used to diagnose most cancers. Instead, it is typically used as a supportive-care and survivorship tool that addresses a common complication in oncology: loss of bone strength and related fractures, which can drive pain, disability, and interruptions in cancer care.
Indications (When oncology clinicians use it)
Oncology clinicians may consider a DEXA scan in scenarios such as:
- Baseline assessment before or soon after starting aromatase inhibitor therapy (commonly used in hormone receptor–positive breast cancer)
- Baseline assessment before or during androgen deprivation therapy (commonly used in prostate cancer)
- Evaluation of premature menopause or ovarian suppression related to cancer therapy
- Long-term or high-dose glucocorticoid (steroid) exposure as part of cancer treatment or supportive care
- Survivorship follow-up in people with history of fragility fractures (fractures from low-level trauma)
- After hematopoietic stem cell transplant or prolonged intensive therapy where bone loss risk may be increased
- Ongoing monitoring when a clinician is tracking known osteopenia/osteoporosis during cancer care
- Assessment when there is concern for vertebral compression fractures (sometimes combined with vertebral fracture assessment, depending on the machine and protocol)
Contraindications / when it’s NOT ideal
DEXA scan is safe for many people, but it may be less suitable or need modification in situations such as:
- Pregnancy or possible pregnancy, because it uses X-rays (another approach may be preferred depending on the clinical question)
- Recent imaging with contrast or radiotracers (for example, some CT contrast studies or nuclear medicine scans), which can interfere with accuracy for a limited time; timing varies by facility protocol
- Inability to lie flat or remain still long enough to acquire accurate images (pain, severe shortness of breath, or certain mobility limitations)
- Body size beyond table or scanner limits, which can reduce image quality or feasibility
- Hardware or anatomic changes at the measured site (for example, hip replacement, spinal instrumentation, or significant spinal degeneration), where alternative measurement sites or methods may be more informative
- Situations where the clinical goal is to evaluate bone metastases or tumor extent; DEXA scan is not designed for staging cancer or mapping metastatic disease, and other imaging is typically used
How it works (Mechanism / physiology)
DEXA scan works by passing two different low-dose X-ray beams through the body and measuring how much energy is absorbed (attenuated) by tissues. Bone absorbs more X-ray energy than soft tissue. Using two energy levels helps the system better separate bone from soft tissue and estimate bone mineral content.
Key concepts clinicians and students often see in DEXA reporting include:
- Areal BMD: DEXA scan estimates bone density over an area (commonly reported as g/cm²). This differs from true volumetric density and is one reason that body size and anatomy can influence results.
- T-score and Z-score:
- T-score compares an adult’s BMD to a young adult reference population and is commonly used in postmenopausal women and older men.
- Z-score compares BMD to an age- and sex-matched reference population and is more often emphasized in premenopausal adults, children, and some secondary causes of bone loss.
Interpretation frameworks can vary by guideline and patient population.
From a physiology standpoint, DEXA scan is indirectly assessing the outcome of bone remodeling, the ongoing balance between bone formation and bone resorption. Many cancer therapies can shift this balance, such as hormone deprivation (lower estrogen or testosterone), which can increase bone resorption and reduce bone strength over time.
Properties like “onset” and “duration” apply more to therapies than imaging tests. A DEXA scan is a snapshot measurement at a point in time. Its clinical value comes from baseline assessment and trend monitoring, where changes can be tracked across repeated scans when performed consistently.
DEXA scan Procedure overview (How it’s applied)
A DEXA scan is an imaging test rather than a treatment. In oncology workflows, it often fits into assessment and follow-up rather than direct intervention. A high-level pathway may look like this:
-
Evaluation/exam
A clinician reviews cancer history, treatment plan, fracture history, menopausal status, medications (including steroids), nutrition factors, activity level, and other medical conditions that affect bone. -
Imaging/labs (as needed)
A DEXA scan may be ordered to measure BMD. Depending on the case, clinicians may also check labs relevant to bone and mineral metabolism (varies by clinician and case). -
Staging
DEXA scan is not a cancer staging test. If cancer staging is needed, other imaging and pathology workflows are used. -
Treatment planning (supportive care)
Results are interpreted alongside clinical risk factors to guide supportive-care planning. This may include fall-risk evaluation, physical therapy or rehabilitation planning, and consideration of bone-protective strategies (specific choices vary by clinician and case). -
Intervention/therapy
If bone health treatment is started, it is typically managed as part of supportive care or survivorship. The DEXA scan itself does not treat bone loss. -
Response assessment
Repeat DEXA scans may be used to monitor trends. Timing of follow-up varies by baseline risk, therapy used, and local protocols. -
Follow-up/survivorship
Bone health monitoring may continue after cancer treatment ends, especially when late effects are possible.
Operationally, many DEXA scans measure the lumbar spine and hip. Some programs also evaluate the forearm or perform add-on assessments depending on clinical context and equipment capabilities.
Types / variations
DEXA scan technology is often described by what part of the body is measured and what the clinical goal is:
-
Central DEXA scan (spine and hip)
Commonly used for diagnosing and monitoring osteoporosis risk. Hip measurements are often emphasized for fracture-risk assessment. -
Forearm (radius) DEXA
May be used when hip or spine cannot be interpreted well (for example, due to hardware or significant degenerative change) or when specific clinical scenarios make forearm assessment helpful. -
Whole-body DEXA scan for body composition
Some centers use DEXA to estimate lean mass and fat mass distribution. In oncology, body composition can be relevant to frailty, functional status, and treatment tolerance discussions, but its clinical use varies by program. -
Vertebral fracture assessment (VFA)
Some DEXA systems can perform a lateral spine image to look for vertebral compression fractures. This is not identical to diagnostic spine radiography but may add useful context in selected patients. -
Screening vs diagnostic use
The same test can be used as a screening tool in higher-risk populations or as a diagnostic evaluation when there is strong concern for osteoporosis or fractures. -
Adult vs pediatric interpretation
Children and adolescents require different interpretation approaches (often focusing on Z-scores and growth considerations), and clinical context is essential.
Pros and cons
Pros:
- Low radiation dose compared with many other imaging tests
- Quick, noninvasive, and typically performed without needles or contrast
- Standardized reporting (BMD values and commonly used score formats)
- Useful for baseline assessment and longitudinal monitoring
- Widely available in many outpatient imaging settings
- Can support survivorship care by tracking treatment-related bone loss
Cons:
- Does not diagnose cancer or reliably evaluate bone metastases
- Measures areal BMD and may not fully capture bone “quality” or microarchitecture
- Accuracy can be affected by degenerative spine changes, scoliosis, fractures, or metal hardware at the measurement site
- Different machines or protocols can complicate comparisons over time if consistency is not maintained
- Body size, positioning, and motion can influence results
- May not fully explain symptoms like bone pain, which often require other evaluation
Aftercare & longevity
There is usually minimal “aftercare” after a DEXA scan because it is a diagnostic test. People typically return to normal activities immediately unless they have other medical restrictions unrelated to the scan.
What affects the longer-term usefulness (“longevity”) of DEXA scan results in oncology depends on context:
- Cancer type and stage: Bone health concerns may be more prominent in some cancers and treatments than others. Varies by cancer type and stage.
- Treatment exposures: Hormone therapies, steroids, transplant-related regimens, and treatment-induced menopause can influence how quickly bone density changes.
- Baseline bone health and comorbidities: Pre-existing osteoporosis, thyroid disease, kidney disease, malabsorption, or other conditions can affect interpretation and follow-up planning.
- Functional status and fall risk: Muscle weakness, neuropathy, balance issues, vision changes, and fatigue can influence fracture risk even when BMD is only mildly reduced.
- Nutrition and rehabilitation support: Access to survivorship services, physical therapy, and supportive care can influence function and fracture prevention strategies (specific recommendations vary by clinician and case).
- Consistency of follow-up: Trends are easier to interpret when repeat scans are done on the same type of machine with consistent technique and at clinically appropriate intervals.
DEXA scan results are typically most meaningful when viewed as part of an overall bone-health assessment rather than a single isolated number.
Alternatives / comparisons
The “best” alternative depends on the clinical question—bone density, fracture detection, or cancer assessment are different goals.
Common comparisons include:
-
DEXA scan vs plain X-ray
X-rays can show fractures and some structural bone changes but do not quantify bone density well until bone loss is advanced. DEXA is better for measuring BMD and tracking change over time. -
DEXA scan vs CT-based approaches (including quantitative CT)
Quantitative CT can estimate volumetric bone density and may provide additional detail, but radiation dose and availability vary. Standard diagnostic CT scans done for cancer care can sometimes provide “opportunistic” bone information, but this is not the same as a standardized DEXA measurement. -
DEXA scan vs ultrasound (peripheral bone assessment)
Heel ultrasound may be used for screening in some settings. It is generally less comprehensive than central DEXA for diagnosis and monitoring and may not be interchangeable for follow-up. -
DEXA scan vs bone scan / PET / MRI for metastases
If the question is whether cancer has spread to bone, clinicians typically use tests like bone scintigraphy, PET imaging, MRI, or CT depending on the cancer type and case. DEXA is not designed for mapping metastatic disease. -
DEXA scan vs clinical risk assessment alone (observation)
Some patients may be followed clinically without immediate imaging, while others benefit from objective baseline measurement. Decisions vary by clinician and case. -
DEXA scan in supportive care vs cancer-directed treatments (surgery, radiation, systemic therapy)
DEXA scan informs bone health management but does not replace cancer treatments. When bone complications are due to metastases, cancer-directed therapy planning typically uses other imaging and oncology decision pathways.
DEXA scan Common questions (FAQ)
Q: Is a DEXA scan painful?
A DEXA scan is usually painless. You lie still on a table while the scanner acquires images. Some people with back or hip pain may find positioning uncomfortable, but the scan itself does not typically cause pain.
Q: Do I need anesthesia or sedation for a DEXA scan?
Anesthesia is not typically used for a DEXA scan. The test is brief and noninvasive. Sedation may be considered only in uncommon situations where a person cannot stay still, and this varies by facility and case.
Q: How long does a DEXA scan take?
The scan is generally quick, and many appointments are completed within a short visit. The exact length depends on the number of sites measured and whether add-on imaging (such as vertebral fracture assessment or body composition) is performed. Scheduling and workflow vary by clinic.
Q: How safe is the radiation from a DEXA scan?
DEXA scan uses a low dose of X-ray radiation compared with many other imaging studies. Even so, it is still radiation, so clinicians consider whether the test is appropriate for the clinical question. If pregnancy is possible, patients are typically asked to inform the imaging team.
Q: Are there side effects after a DEXA scan?
Side effects are uncommon because there is no injection, incision, or contrast dye in standard DEXA scanning. Most people resume normal activities right away. Any discomfort is usually related to lying still or positioning rather than the scan itself.
Q: Will a DEXA scan show bone metastases or cancer in the bone?
DEXA scan is not designed to detect or stage bone metastases. It measures bone density and may incidentally note certain abnormalities, but it does not replace cancer imaging. If metastases are a concern, clinicians typically use other imaging tailored to the cancer type.
Q: How much does a DEXA scan cost?
Cost varies by country, health system, insurance coverage, and whether the scan is performed in a hospital or outpatient imaging center. Additional components (such as body composition or vertebral assessment) may change pricing. Billing rules and coverage vary by clinician and case.
Q: Can I go back to work or exercise after the scan?
Most people can return to usual activities immediately after a DEXA scan. Any restrictions would typically be related to the underlying health condition being evaluated rather than the test. If you have mobility limitations, the imaging team may provide positioning support.
Q: Can a DEXA scan affect fertility, or is it safe during pregnancy?
A DEXA scan does not affect fertility. However, because it uses X-rays, it is generally avoided during pregnancy unless there is a specific reason and appropriate precautions are taken. If pregnancy is possible, imaging teams usually ask about this beforehand.
Q: How are results used in cancer care and survivorship?
In oncology, DEXA results are often used to identify and monitor treatment-related bone loss and to support fracture-risk reduction planning. They are interpreted alongside cancer treatment history, medications (such as hormone therapies or steroids), and other risk factors. Follow-up timing and next steps vary by clinician and case.